| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $32.5M | +106.8% | +1471.6% |
| R&D Expense | $2.8M | -31.8% | -37.8% |
| SG&A Expense | $74.8M | +37.6% | +287.7% |
| Operating Income | -$53.2M | -11.7% | -144.6% |
| Net Income | -$51.2M | -14.0% | -167.4% |
| EPS (Basic) | -$0.52 | -13.0% | -160.0% |
| EPS (Diluted) | -$0.52 |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $59.6M | +15.6% | +50.2% |
| Short-term Investments | $228.7M | +21.2% | +38.6% |
| Accounts Receivable | $36.5M | +45.1% | +4615.5% |
| Inventory | $21.4M | -3.1% | +2896.8% |
| Current Assets | $338.9M | +20.4% | +62.3% |
| Total Assets |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$127.4M | — | — |
| Capital Expenditures | $339K | — | — |
| Investing Cash Flow | $32.7M | — | — |
| Financing Cash Flow | $103.5M | — | — |
| Free Cash Flow | -$127.7M | — | — |
| -13.0% |
| -160.0% |
| $372.8M |
| +18.9% |
| +71.3% |
| Current Liabilities | $50.9M | +11.6% | +206.1% |
| Long-term Debt | $96.2M | — | — |
| Total Liabilities | $225.1M | +85.8% | +1254.4% |
| Stockholders' Equity | $147.7M | -23.2% | -26.5% |